Biller Jonathan sold VRTX

February 13, 2026 · Form 4 insider transaction

Biller Jonathan sold 988 shares of Vertex Pharmaceuticals Incorporated at $499.00 per share, a transaction worth $493.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 5 days after the transaction.

Direction
Disposed (sell-side)
Shares
988
Price
$499.00
Total value
$493.0K
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 13, 2026
Filing dateFebruary 18, 2026
Shares owned after16,838
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

Transaction made pursuant to Mr. Biller's company approved trading plan under Rule 10b5-1, which was entered into on 02/24/2025.

View the original Form 4 on SEC EDGAR